Directory · CH
Biotechnology Research in Switzerland
A register of firms and the professionals working at them in the Biotechnology Research sector based in Switzerland. Browse the public index, then filter or export on Kipplo.
Companies
522 on file
Limmatech Biologics Ag
LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK.
51 to 200 staff
Lyo-X Ag
LYO-X provides strategic consulting and PK/PD modelling services dedicated to the preclinical and clinical development of biologics and cell based therapies. Our speciality are drug formats at the scientific edge: bi-specifics, antibody-drug conjugates, scFv’s, nanobodies and cell based therapies. Whatever your therapeutic approach, we have the expertise in biology, pharmacology, mathematical modeling and drug development to provide tailored support for your unique program. We apply systems pharmacology for target assessment, format selection, compound design, candidate selection, design and analysis of preclinical PK/PD and GLP toxicology studies, first in human dose selection, dose / regimen finding studies and paediatric drug development. Our customers are biotechnology start-ups, pharmaceutical companies and CROs. LYO-X is part of the iBx Network. The iBx Network provides integrated services in toxicology, pharmacology, preclinical and clinical development in combination with modelling and simulation. For more information see
1 to 10 staff
Mycrobez Ag
Die Mycrobez AG ist die Verkörperung der Idee, eine nachhaltigere Zukunft durch die Ökonomisierung von grüner Technologie zu schaffen. Seit der Gründung im Jahr 2019 arbeitet unser interdisziplinäres Team aus Fachleuten der Materialwissenschaft, Biologie sowie Labor- und Verfahrenstechnik daran, eine weltweit einmalige Technologieplattform zu schaffen. Diese ermöglicht die vollautomatisierte Aufwertung von Biomüll durch Pilzwurzeln (Myzel) zu einem multifunktionalen Naturschaumstoff. Das sogenannte Myzelkomposit wird dabei nicht nur nachhaltiger als seine erdölbasierten Kontrahenten, sondern auch profitabler. Das Produkt ist eine industriell skalierbare Alternative für Verpackungen, und Düngemittel. Die Wirtschaftlichkeit und die Vielseitigkeit dieses Werkstoffes gibt uns die Möglichkeit, einen internationalen und branchenübergreifenden Beitrag zu einer funktionierenden Kreislaufwirtschaft zu leisten. Durch die Verbindung von Innovation, Nachhaltigkeit und unternehmerischer Entschlossenheit kann die Vision einer Bioökonomie umgesetzt und damit ein vielversprechender Nährboden für die Generationen von morgen geschaffen werden. Bei der Umsetzung dieser Mission wird die Mycrobez AG von renommierten wissenschaftlichen Institutionen, dem Migros Pionierfonds, der Klimastiftung Schweiz sowie diversen branchenführenden Unternehmen unterstützt und beraten.
11 to 50 staff
Adaptyv
Proteins are the most advanced nanotechnology we know of. At Adaptyv Bio we’re building a next-gen protein foundry to allow you to synthesize and test any protein you design.
11 to 50 staff
Alveolix
Our Vision We aim at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs’ responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing. Our Mission AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
11 to 50 staff
Boum
Swiss Eco-Tech Startup developing smart solutions for the green cities of the future: IoT Hardware, Software & Bioware.
1 to 10 staff
Ductor Corp
Ductor Corporation is a Finnish biotechnology company providing biogas operators with a unique portfolio of proprietary, patented and tested technologies for improving the profitability and stability of their biogas businesses. Ductor's biological fermentation technology removes a controlled amount of nitrogen from the substrate prior to the anaerobic digestion process. Ductor promotes biogas as one of the most important renewable energy sources, while supplying important food production components as fertilizers.
11 to 50 staff
Leadxpro Ag
LeadXpro was founded in 2015 as a spin-out from the Paul Scherrer Institute (ETH) and is located between Zurich and Basel. The company aims to revolutionize the way drugs are being discovered for membrane proteins (e.g, GPCRs, ion channels, enzymes, transporters). These protein targets constitute more than half of the current drug targets but have not yet been fully amenable to structure-based drug design due to the considerable challenges in solving their atomic structures. To achieve our goal, we combine state-of-the-art methods for membrane protein science together with pioneering technologies in structural biology (Cryo-EM, XFEL). Our business model includes working in collaboration with Pharma/Biotech clients on their protein target of interest allowing them to keep their target exclusivity and all IP rights. We provide specialized expertise in areas such as construct design, protein generation, biophysical characterization of ligand interaction, crystallization, X-ray crystallography, electron microscopy and data analysis with computational methods. We also provide a lead discovery and optimization platform with the goal to deliver novel leads for challenging membrane protein targets. Find out more at
11 to 50 staff
Memo Therapeutics Ag
Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid structure biology. The Company has a partnership in place with Ono Pharmaceutical for two oncology targets. Underpinning MTx’s core assets is its proprietary DROPZYLLA® technology, an antibody repertoire copying engine with high-throughput screening capabilities. MTx is a private company located in Schlieren / Zurich and backed by investors including Ysios Capital, Kurma Partners, Pureos Bioventures, Swisscanto, Vesalius Biocapital and Adjuvant Capital.
11 to 50 staff
Mimix Biotherapeutics
MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality. Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation. We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community Visit to learn more. mimiX biotherapeutics is a Swiss biomedical company.
11 to 50 staff
Mpc Therapeutics
At MPC Therapeutics, we are convinced that mitochondria, the small organelles at the core of the cell's metabolism, represent untapped therapeutic targets. Headquartered in Switzerland, our startup is focused on cellular rejuvenation to improve the performance of cell therapies and treat degenerative pathologies. Our novel approach uses proprietary first-in-class small molecules that specifically target mitochondria to trigger metabolic reprogramming. Visit our website for more info.
1 to 10 staff
Precomb
PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It’s automated microtumor-based 3DTwin™ technology enables clinical institutions to integrate the technology on-site in the hospital. The test makes it possible to functionally evaluate multiple cancer drugs, drug combinations and drug concentrations directly on patient-derived micro-tumors to maximize treatment outcome.
1 to 10 staff
Valleydao
Welcome to ValleyDAO, a pioneering community dedicated to addressing critical climate and food challenges through the funding of academic research in the field of biotech and industrial biotechnology. Our mission is to accelerate innovation in tackling climate change, a problem we recognize as a pressing reality. Our approach is unique: we believe in the power of collaboration and interdisciplinary efforts in the complex field of synthetic biology. ValleyDAO aims to dissolve academic silos, granting researchers access to an expert community for early-stage research development and funding. What We Offer: Research Funding and Market Integration: We offer up to in funding, aligning research with business objectives to ensure that each experiment contributes towards viable commercial outcomes. Intellectual Property Incubation: For those with patents or in the process of securing them, we provide comprehensive support. This includes assistance in tech transfer, C-team formation, business development, and fundraising. Expert Community Network: Our community, comprised of academics, entrepreneurs, investors, and professionals, offers support in areas of funding and IP development. Community Co-ownership: Members of ValleyDAO are more than participants; they are co-owners. Through their contributions, they earn shares or digital tokens ($GROW) in the organization, granting them voting rights and a stake in the success of our supported research and spinouts. This ownership model fosters deep engagement and active involvement in our collective mission. Join us in driving innovation and addressing the global climate challenge. Researchers can apply for funding here: And those interested in joining our community can sign up here:
1 to 10 staff
Amal Therapeutics
Amal Therapeutics is a Biotechnology company located in 64 av, de la Roseraie, 1205 Geneva, Switzerland.
11 to 50 staff
Avintos Ultrapure
Single-use assemblies for manufacturing in biopharma & life sciences. OUR VIEW Consider the following questions: Are you still assembling yourself? Are you still sourcing all these tiny compononents yourself? If you answer one of them with a "yes"- that's the moment where we come in. We carefully maintain a global network of trusted suppliers & closely work with assembling companies which do assemble full time. OUR COMPETENCE Components and Assemblies meet the currently required specifications in terms of quality, validation and compliance with international standards. We also build small series of tube connections, sampling systems, container and assemblies with sensors, filters and pumps according to the requirements of the customer application. OUR FUTURE At avintos we have the ambition to become your first choice as a supplier of single use assemblies. From your inquiry through to our delivery. Your need is our motivation.
1 to 10 staff
Baselaunch
BaseLaunch is the Basel-based incubator and accelerator that helps scientists and entrepreneurs launch exceptional biotech companies. It serves as a growth platform for early-stage ventures developing cutting-edge therapeutics. BaseLaunch helps build companies from inception through to Series A funding, providing financing and supporting all aspects of company creation and growth. It is operationally run and financed by Basel Area Business & Innovation, the investment and innovation promotion agency helping companies, institutions and startups find business success in the Basel area. BaseLaunch partners with leading global pharma and biotech companies and a venture fund – AbbVie, Roche, Novo Nordisk, Johnson & Johnson, CSL, and Pureos Bioventures, which also feed into the pool out of which BaseLaunch funds ventures. Domain and regional partners include KPMG, Vossius & Partner, Alloy Therapeutics, Walder Wyss attorneys at law, WuXi AppTec, Lonza, Charles River Laboratories, Wuxi Biologics, BioDuro, VISCHER as well as the Tech Park Basel, and the Switzerland Innovation Park Basel Area. Since 2018, BaseLaunch supported ventures have raised in total over US$ 800 million. Harnessing the Basel area’s unique position as a global life sciences hub, as well as its rising popularity among investors, BaseLaunch is looking to attract the next generation of breakthrough companies. Interested groups can find more information at
1 to 10 staff
Bioreba Ag
We are Agro-Diagnostic. Since 1980 BIOREBA is a biotech company providing diagnostic tests for the detection of plant pathogens. Our high-quality products are available worldwide. BIOREBA has been awarded to ISO 9001 and ISO/IEC 17025 for analyses of plant pathogens. Since November 2023, BIOREBA is part of the international Calibre Scientific group. Research institutions and diagnostic laboratories around the world rely on our validated products like ELISA, PCR, or AgriStrip for testing potatoes, vines, fruit trees, small fruits, vegetables, ornamental plants, and field crops. Our HOMEX and Extraction Bags have been established for sample preparation in a large number of labs worldwide. Farmers, growers, and nurseries value our fast and customer-friendly testing services. We are committed to providing excellent products and services and never stop working on the further development of new products and solutions. Our Mission: with the detection of plant diseases, we enable to promote a stable, consistent food supply for humans and animals worldwide. Visit bioreba.com or testplant.ch to learn more.
11 to 50 staff
Biotechgate
A product of Venture Valuation, Biotechgate is a comprehensive life sciences database where business development professionals and investors discover new companies and create strong partnerships. Encompassing information on companies, clinical trials, licensing opportunities and more, find out why Biotechgate is the trusted life sciences business development solution with a complimentary demo today.
11 to 50 staff
Dualsystems Biotech
Dualsystems Biotech is a service provider for custom proteomics for industry and academia. We identify the targets and off-targets at the cell membrane on the living cells using the ligand-receptor capture LRC-TriCEPS™ technology (LC-MS/MS based). Target identification can be performed for ligands such as proteins, peptides, and viruses. With the new version of TriCEPS™ we have evidence that even small molecule targets can be identified. With our Flow-TriCEPS ™ technology we can optimize the binding conditions prior to the main identification experiment
1 to 10 staff
Edelweiss Connect
Edelweiss Connect is a Swiss company located in Basel, specialised in developing and implementing integrated scientific and technology solutions for industrial use and regulatory acceptance in areas of significant societal and market impact. Our mission is to provide solutions addressing a range of important industrial safety problems supporting a safer intelligent design and risk assessment of products and their use (https://saferworldbydesign.com/). Towards this goal we work with our partners to provide a central place and platform where problems can be solved based on a combination of in silico and in vitro new approach methods. We have extensive experience in scientific research and innovation integrating data, in silico and in vitro methods and related infrastructure into solutions, and have been involved in organising scientific, technical and knowledge management solution development projects since 2008. Edelweiss Connect provides the expertise and experience to initiate, coordinate and manage large collaborative research projects, with partners from industry, government and academia. Our goal is to incubate high impact products, services and solutions at the forefront of innovation, with sustainability and responsibility. We are also committed to human wellness and supporting the conservation of diverse ecosystems, wildlife, and biodiversity for future generations.
11 to 50 staff
Epithelix
Epithelix Sàrl is a Swiss biotech company specialized in human tissue engineering. Epithelix provides innovative R&D solutions for the study of human respiratory diseases (e.g. Asthma, COPD, Cystic Fibrosis, etc.) and for inhalation toxicity testing of chemicals, while reducing the number of animal experiments.
11 to 50 staff
Evax Ag
For many equine diseases only limited therapeutic treatment options are available with sometimes poor efficacy. Hence, there is a major need for new, innovative, specific and efficacious equine therapeutics. Our mission is to transfer human standards of care into horses at an affordable price.
1 to 10 staff
Geneuro Sa
GeNeuro is a biotechnology company developing innovative treatments against inflammatory and neurodegenerative disorders associated with Human Endogenous Retroviruses (HERVs). We are committed to fight the progression of disability in Multiple Sclerosis #FightMS and other neurodegenerative diseases #ALS #LongCOVID Our Community Guidelines: http://bit.ly/36y9YCE
11 to 50 staff
Hamilton Bonaduz Ag
The global Hamilton Group, based in Bonaduz and Domat / Ems, Hamilton Bonaduz AG, Hamilton Medical AG, Hamilton Storage GmbH and Hamilton Ems AG, is one of the technology leaders in life science, storage, measurement and medical technology. The success story is based on the invention of the microliter syringe in the late 1940s by American chemical engineer Clark Hamilton. Today Hamilton produces precision instruments for research and industry as well as intelligent ventilators. In addition, the company is strongly represented in the growth markets of genetics and robotics. Currently, the group employs around people worldwide, more than 1200 of them in Bonaduz and Domat / Ems. The company is wholly owned by the Hamilton family and has been managed by CEO Andreas Wieland since 2001.
1001 to 5000 staff
Hydroliq Ag
Hydroliq is a Swiss company that produces ecological disinfectant solutions based on stable hypochlorous acid (HOCL). Our unique electrolysis process produces biocidal products that eliminate viruses, multi-resistant bacteria, spores and fungi. All our products are free from hazardous substances and have been dermatologically tested and found to be "VERY GOOD".
11 to 50 staff
Merrick Biotech
Merrick Biotech stands at the forefront of biotechnological innovation, rooted in the heart of Switzerland, with a vision deeply invested in the pursuit of extending human life and advancing the field of biological engineering science. Our commitment lies in spearheading transformative research and development initiatives aimed at unlocking the mysteries of aging, enhancing human health, and pioneering breakthroughs that could redefine the boundaries of medicine and science. With a team comprising some of the brightest minds in biotechnology, genetics, and related disciplines, Merrick Biotech operates at the intersection of cutting-edge research and practical application. Our laboratories are equipped with the latest technologies, fostering an environment where experimentation and discovery thrive. Our work is guided by a philosophy that the complexities of biology can be engineered for the betterment of human longevity, ensuring a future where life is not just longer but also significantly enriched in quality. Our areas of focus include but are not limited to, regenerative medicine, genetic engineering, and the development of novel therapeutics aimed at combating age-related diseases. Merrick Biotech is dedicated to ethical and sustainable research practices, emphasizing the importance of responsible innovation in every project we undertake. As we continue to explore the vast potential of biotechnology, Merrick Biotech is committed to contributing meaningful advancements to the field, with the ultimate goal of creating a future where the human lifespan is significantly extended, and healthspan is improved, allowing individuals to live fuller, healthier lives. Through collaboration, dedication, and a relentless pursuit of excellence, Merrick Biotech is shaping the future of human health and longevity, one discovery at a time.
201 to 500 staff
Osr Holdings
OSR Holdings is a hub-and-spoke healthcare group. Our vision is to accelerate healthcare innovation to improve health and wellness outcomes globally. Guided by values of integrity, transparency, and collaboration we seek to create lasting benefits for patients, their families, and the broader community by combining cutting-edge science with responsible corporate stewardship. Our current areas of focus include oral T-cell mediated immunotherapies, disease modifying osteoarthritis drug (DMOAD), and noninvasive glucose monitoring (CGM)
1 to 10 staff
Readily3d
Readily3D develops ultra-rapid, user friendly 3D printers. Our volumetric printing technology enables the fabrication of complex structures in a matter of seconds.
1 to 10 staff
Regenhu
REGENHU, the Swiss Med Tech 3D Bioprinting pioneer, started in 2007 with the goal to create and develop bioprinting technologies that will positively impact medicine. Today we remain strong believers in this vision and are driven to its realization. We are an ambitious, passionate and dynamic team that are building research 3D Bioprinters and software for our customers today, with the view to creating the instruments that will provide their manufacturing needs of the future. Our customer focused approach, visionary outlook, advanced instruments and user-friendly software that perform their tasks with accuracy and repeatability, are at the heart of everything REGENHU does. Our commitment to our users, present and future, is that we will stay with them through their journey, with bioprinting instruments that enhance their ability to realize their research goals, however ambitious. With our instruments the REGENHU team are bringing the future closer, we are revolutionizing medicine today.
11 to 50 staff
Risklick
Discover the first-in-class AI software reinventing clinical trial protocol development. Protocol AI empowers experts to conduct faster, cheaper and safer trials, paving the way to medical innovation.
11 to 50 staff
Swiss Biotech Association
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.
1 to 10 staff
Tigen
We are a clinical-stage biotech company in the field of cell therapies to cure cancer. We are a disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class capabilities and a long-term perspective to the benefit of patients and society.
11 to 50 staff
Vandria Sa
We are developing first-in-class small molecules against a novel target to improve mitochondrial function and reduce chronic inflammation to treat age-related diseases.
1 to 10 staff
4bases Sa
4Bases S.A. is a company created in 2013 to develop and produce molecular diagnostic kits for genetics tests of diseases such as cancer. 4Bases has it head office in Manno, Ticino, Switzerland.
11 to 50 staff
Acm Biolabs
ACM Biolabs • Innovative medicines through next generation targeted delivery. • Versatile platform for infectious disease prevention and therapies. We are based in two world leading innovation hubs for biotechnology: Singapore and Switzerland. Embedded in a rich ecosystem of pharmaceutical companies, biotechs, and institutional and private investors, we believe this is a valuable success factor to advance our science and pipeline programs. Our experienced team with senior ex-pharma veterans provide a basis to attract talent, partners and investors. As a dedicated team combining pharmaceutical industry, biotech, and academic excellence we develop prophylactic treatment and therapeutic vaccines for infectious diseases and therapeutic vaccines for personalized cancer treatment based on our proprietary polymer based delivery platform technology. We believe in challenging the status quo of targeted delivery in medicines and we are revolutionizing the new medicines with ACM platform. We develop these transformative medicines to treat or prevent diseases in a safe and well tolerable 1. Our delivery is targeted to antigen-presenting cells. These dendritic cells are best suited to educate the immune system in an elegant way against virus antigens. Therefore, only low amounts of payloads in ACMs are needed. ACM delivery are only made of a few components, self-assemble and encapsulate proteins, peptides, and mRNA. That means an easy manufacturing process for vast amounts of bulk product. Our payload is protected at refrigerator temperatures. We can store mRNA at 4°C making storage and transport much easier.
11 to 50 staff
Acrobiosystems Ag
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics. ACROBiosystems’ brands include FLAG, Star Staining, ViruStop, Aneuro, ComboX, GENPower, and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics. Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.
11 to 50 staff
Helvetica Health Care
Helvetica Health Care supply high quality biotechnology products with an unrivaled delivery service to all over the world from our distribution center in Geneva (Switzerland). Our company is ISO 13485:2016 certified. We have many years trading experience with all continents and have developed an important network of contacts. This allows us to provide the best commercial and technical support to our customers and offer shipping and delivery services to any destination with the guarantee of effective control and monitoring services.
1 to 10 staff
Newbiologix
Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies.
11 to 50 staff
Ridgeline Discovery
Ridgeline, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe, US and RoW. In recent years, Ridgeline has assembled an international team of highly experienced drug discovery and industry professionals and built and operated multiple new successful companies; these companies have raised significant funds through Series B, IPO, Pharma Partnerships and an exit through a trade sale.
11 to 50 staff
Sfl Is Now Veristat
SFL, a Veristat company - Integrated Solutions for Healthcare Products SFL is a leading consultancy providing integrated solutions to pharma, biotech and medtech companies for all product life cycle stages: Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, Medical Writing, Public Affairs & Market Access, Pharmacovigilance, and Healthcare Compliance. In addition, SFL can act as marketing authorization applicant and MAH in Switzerland and the EU and conduct submissions to FDA, PMDA and Health Canada and other authorities. As a Veristat company, SFL clients also have access to a substantial range of clinical development services such as global clinical operations, biostatistics and programming.
11 to 50 staff
T3 Pharmaceuticals Ag
Developing the next generation bacterial cancer therapy The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria. T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of live bacteria. While the technology has diverse applications in research, T3 Pharma has further developed the system to serve as a novel therapeutic to treat solid tumors.
11 to 50 staff
Witec Ag
YOUR TRUSTED SWISS DISTRIBUTION PARTNER FOR LIFE SCIENCE RESEARCH SINCE 1988 Supplying cutting-edge instruments and reagents to propel scientific discovery. OUR EXPTERTISE, YOUR ADVANTAGE: Western Blot Imaging & Gel Documentation: Capture clear and reliable protein data. Spectrophotometry: Ensure accurate and precise measurements for your experiments. Cell Biology & Protein Analysis: Unravel the complexities of cellular function. Genomics Research: Unlock the power of genetic information. Single Cell Technologies: Explore the unique characteristics of individual cells. BEYOND PRODUCTS: BUILDING STRONG PARTNERSHIPS We believe in the power of collaboration. That's why we go beyond simply supplying equipment. Our exceptional customer service ensures you have the support you need to achieve your research goals. Our commitment to finding the best solutions for your specific needs sets us apart. AGILITY AND INNOVATION: THE WITEC DIFFERENCE At Witec AG, we operate with a networked, agile, and flexible approach. This allows us to stay at the forefront of scientific advancements and deliver the most innovative solutions to our customers. Ready to take your research to the next level? Contact us!
1 to 10 staff
Akymed
AKYmed is building the new standard for semen quality and genetic stewardship—across people, production animals, and conservation. QualiSperm & QualiSperm Cloud: patented CASA tech + secure cloud workflows for fast, reproducible diagnostics—on site or pay-per-analysis. Noah Genetics (our animal brand): a full AI toolbox covering diagnostics, genomic optimization (pairing/selection, breeding plans), and long-term preservation (cryopreservation & biobanking), plus proven extenders for reliable logistics. Who we serve: fertility clinics & andrology labs; veterinary labs; aquaculture hatcheries; livestock and fish producers; companion-animal breeders; conservation/restoration projects. If semen quality, genetic diversity, and operational efficiency matter to you—we’d love to connect.
1 to 10 staff
Anokion
Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.
11 to 50 staff
Doppl Sa
DOPPL SA is a leader in engineering industry-standard organoids for disease modeling and personalized medicine. We engage in partnered projects for preclinical drug development by providing relevant, high-quality, and scalable organoid models.
11 to 50 staff
Esperare Foundation
EspeRare is a not-for-profit organization established in Switzerland and recognized to be operating in the public interest. In collaboration with patient groups and other key stakeholders, EspeRare focuses on rescuing and repositioning discontinued therapies with high potential to address severe and currently neglected therapeutic needs of children affected by rare genetic diseases. EspeRare is using its pharma R&D expertise and patient-centric model to advance novel treatments for the undeserved patients, thus bringing hope for better future to these children and their families.
1 to 10 staff
Invirtuolabs
InVirtuoLabs is a new-generation laboratory for drug discovery. We design novel drugs by combining advanced machine learning techniques with physics-based simulations to rapidly identify and optimize promising drug candidates.
1 to 10 staff
Mirai Foods
We are developing real meat - cultivated directly from animal cells! Our mission is to provide delicious, high quality cultivated meat at a fair price. Better for people, animals and the planet. Our vision is to become a household brand for cultivated meat, thereby accelerating the transition to a global food system that is environmentally, ethically and economically sustainable.
11 to 50 staff
